Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GENENTECH INC

  • FDA Approval
  • Sept. 13, 2024, 16:36 UTC
  • 51
  • 0 comments

FDA approve OCRELIZUMAB;HYALURONIDASE-OCSQ

Comment Full text

MSN

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 36
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

PROPEL PHARMA

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 40
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

PYROS PHARMS

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 41
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

GRANULES

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 44
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 39
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

UPSHER SMITH LABS

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 45
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 48
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

HIKMA

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 47
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 49
  • 0 comments

FDA approve VIGABATRIN

Comment Full text
  • Previous
  • 355
  • 356
  • 357
  • 358
  • 359
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158464)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin